Carroucell Raises €1.5 Million To Introduce Breakthrough Microcarriers And Customizable Processes To Cell And Gene Therapy Market
Carroucell Raises €1.5 Million To Introduce Breakthrough Microcarriers And Customizable Processes To Cell And Gene Therapy Market
09/07/22, 7:05 AM
Location
grenobleMoney raised
€1.5 million
Industry
biotechnology
manufacturing
Round Type
seed
Carroucell, the microcarrier supplier for cell culture in bioreactor, announced today that it has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the Novalis Biotech Acceleration fund and with participation of Crédit Agricole des Savoie (CADS), as well as support from Bpifrance. The funding will be used to accelerate corporate growth through industrialization of the company’s platform technology and ramping up of mass production processes to GMP standards.
Company Info
Location
grenoble, auvergne rhône alpes, france
Additional Info
Carroucell is a biotech company who provides innovative solutions continuously into the bioproduction market more specifically the biomanufacturing field in creating the next generation of microcarrier technologies. Carroucell solutions solve enormous current challenges and issues regarding the performance of the biomanufacturing. Our ambition and mission are to impact positively the bioproduction performance through our disruptive microcarriers in addition to our agile approach to create a new future for all patients who can get a better access to the therapeutic innovations.